Pendragon PLC - PDG.L

PDG.L Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
PDG.L	0	-5.1	3.0	11.1	98.8	95.3	112.9	30.9	12.0	628.6
S&P 500	0.6	1.5	2.6	4.0	9.4	25.5	38.0	83.2	195.0	34364.2

Compare PDG.L with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	PDG.L
name	Pendragon PLC
price	35.55
changes percentage	0.1408
change	0.05
day low	35.55
day high	35.55
year high	36.698
year low	35.55
market cap	619391211
price avg 50	33.929
price avg 200	26.39865
exchange	LSE
volume	57420
avg volume	9818764
open	None
previous close	35.5
eps	0.03
pe	11.85
earnings announcement	2024-03-20T07:00:00.000+0000
shares outstanding	1742310016
timestamp	2024-02-13 16:59:57

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 50.0%

Overall Quarterly Financial Health: 68.0%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2022	2021	Y/Y change %
0000000000
revenue	3620000000	3421300000	5.81
gross profit	457200000	437300000	4.55
gross profit ratio	0.13	0.13	-1.19
research and development expenses	1200000	1000000	20.00
operating expenses	363900000	326500000	11.45
interest income	1000000	900000	11.11
interest expense	42200000	34900000	20.92
ebitda	125500000	147800000	-15.09
ebitdaratio	0.03	0.04	-19.94
operating income	101000000	112600000	-10.30
operating income ratio	0.03	0.03	-15.23
net income	45500000	61500000	-26.02
net income ratio	0.01	0.02	-30.08
eps	0.03	0.04	-25.00

Overall Score of Annual Income Statement

0.38 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 3,620 million in 2022 from 3,421 million in 2021 representing a change of 5.81%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 457 million in 2022 from 437 million in 2021 representing a change of 4.55%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 1 million in 2022 from 1 million in 2021 representing a change of 20.0%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 364 million in 2022 from 326 million in 2021 representing a change of 11.45%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 126 million in 2022 from 148 million in 2021 representing a change of -15.09%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 101 million in 2022 from 113 million in 2021 representing a change of -10.3%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to 46 million in 2022 from 62 million in 2021 representing a change of -26.02%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.03 in 2022 from 0.03 in 2021 representing a change of -25.0%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2023Q2	2022Q4	Q/Q change %
0000000000
revenue	2090000000	1774500000	17.78
gross profit	216200000	190100000	13.73
gross profit ratio	0.1	0.11	-3.44
research and development expenses	0	2450000	-100.00
operating expenses	152500000	143700000	6.12
interest income	400000	500000	-20.00
interest expense	27400000	22800000	20.18
ebitda	98300000	81300000	20.91
ebitdaratio	0.05	0.05	2.66
operating income	63700000	46400000	37.28
operating income ratio	0.03	0.03	16.56
net income	26900000	19100000	40.84
net income ratio	0.01	0.01	19.58
eps	0.02	0.01	40.88

Overall Score of Quarterly Income Statement

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 2,090 million in 2023Q2 from 1,774 million in 2022Q4 representing a change of 17.78%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 216 million in 2023Q2 from 190 million in 2022Q4 representing a change of 13.73%. This indicates a sales profitability growth, which is a positive sign for the company.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 98 million in 2023Q2 from 81 million in 2022Q4 representing a change of 20.91%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 64 million in 2023Q2 from 46 million in 2022Q4 representing a change of 37.28%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 27 million in 2023Q2 from 19 million in 2022Q4 representing a change of 40.84%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.02 in 2023Q2 from 0.02 in 2022Q4 representing a change of 40.88%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 0 million in 2023Q2 from 2 million in 2022Q4 representing a change of -100.0%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Expenses: Operating Expenses increased to 152 million in 2023Q2 from 144 million in 2022Q4 representing a change of 6.12%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2022	2021	Y/Y change %
0000000000
total assets	1619000000	1367200000	18.42
total liabilities	1338000000	1141600000	17.20
total equity	281000000	225600000	24.56
cash and cash equivalents	171900000	37600000	357.18
short term investments	0	0	NaN
long term investments	14800000	15500000	-4.52
total current assets	919700000	668700000	37.54
total non current assets	699300000	698500000	0.11
total current liabilities	974400000	756600000	28.79
total non current liabilities	363600000	385000000	-5.56
common stock	69900000	69900000	0.00
retained earnings	135600000	80700000	68.03
total debt	413100000	309400000	33.52

Overall Score of Annual Balance Sheet

0.62 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 1,619 million in 2022 from 1,367 million in 2021 representing a change of 18.42%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 281 million in 2022 from 226 million in 2021 representing a change of 24.56%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 172 million in 2022 from 38 million in 2021 representing a change of 357.18%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 920 million in 2022 from 669 million in 2021 representing a change of 37.54%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 136 million in 2022 from 81 million in 2021 representing a change of 68.03%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 1,338 million in 2022 from 1,142 million in 2021 representing a change of 17.2%. This indicates an increase in overall liabilities.

  Total Current Liabilities: Total Current Liabilities increased to 974 million in 2022 from 757 million in 2021 representing a change of 28.79%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 413 million in 2022 from 309 million in 2021 representing a change of 33.52%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2023Q2	2022Q4	Q/Q change %
0000000000
total assets	1698900000	1619000000	4.94
total liabilities	1390400000	1338000000	3.92
total equity	308500000	281000000	9.79
cash and cash equivalents	271900000	171900000	58.17
short term investments	0	0	NaN
long term investments	13700000	14800000	-7.43
total current assets	1000500000	919700000	8.79
total non current assets	698400000	699300000	-0.13
total current liabilities	1029600000	974400000	5.67
total non current liabilities	360800000	363600000	-0.77
common stock	69900000	69900000	0.00
retained earnings	163300000	135600000	20.43
total debt	441200000	413100000	6.80

Overall Score of Quarterly Balance Sheet

0.62 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 1,699 million in 2023Q2 from 1,619 million in 2022Q4 representing a change of 4.94%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 308 million in 2023Q2 from 281 million in 2022Q4 representing a change of 9.79%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 272 million in 2023Q2 from 172 million in 2022Q4 representing a change of 58.17%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 1,000 million in 2023Q2 from 920 million in 2022Q4 representing a change of 8.79%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 163 million in 2023Q2 from 136 million in 2022Q4 representing a change of 20.43%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 1,390 million in 2023Q2 from 1,338 million in 2022Q4 representing a change of 3.92%. This indicates an increase in overall liabilities.

  Total Current Liabilities: Total Current Liabilities increased to 1,030 million in 2023Q2 from 974 million in 2022Q4 representing a change of 5.67%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 441 million in 2023Q2 from 413 million in 2022Q4 representing a change of 6.8%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2022	2021	Y/Y change %
0000000000
net change in cash	31800000	-18400000	272.83
operating cash flow	76100000	63200000	20.41
free cash flow	31800000	44600000	-28.70
capital expenditure	-44300000	-18600000	-138.17
depreciation and amortization	33500000	36100000	-7.20
deferred income tax	8800000	-30400000	128.95
stock based compensation	3300000	2900000	13.79
accounts payables	150800000	-111100000	235.73
inventory	-119800000	107800000	-211.13
acquisitions net	3900000	27200000	-85.66
investments in property plant and equipment	-44300000	-18600000	-138.17
net cash used for investing activites	-25100000	16200000	-254.94
debt repayment	0	0	NaN
common stock issued	100000	0	NaN
common stock repurchased	-500000	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	-19300000	-97300000	80.16
cash at end of period	69400000	37600000	84.57
accounts receivables	-15200000	-1100000	-1281.82
cash at beginning of period	37600000	56000000	-32.86

Overall Score of Annual Cashflow Statement

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 32 million in 2022 from -18 million in 2021 representing a change of 272.83%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 76 million in 2022 from 63 million in 2021 representing a change of 20.41%. This indicates that the company generated more cash from its core business operations.

  Capital Expenditure: Capital Expenditure decreased to -44 million in 2022 from -19 million in 2021 representing a change of -138.17%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Receivables: Accounts Receivables decreased to -15 million in 2022 from -1 million in 2021 representing a change of -1281.82%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• 📉 Negative Indicators

  Free Cash Flow: Free Cash Flow decreased to 32 million in 2022 from 45 million in 2021 representing a change of -28.7%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Deferred Income Tax: Deferred Income Tax increased to 9 million in 2022 from -30 million in 2021 representing a change of 128.95%. This indicates that the company's tax liability for future periods has increased.

  Stock-Based Compensation: Stock-Based Compensation increased to 3 million in 2022 from 3 million in 2021 representing a change of 13.79%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables increased to 151 million in 2022 from 111 million in 2021 representing a change of 235.73%. This indicates that the company has increased its outstanding obligations to its suppliers.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023Q2	2022Q4	Q/Q change %
0000000000
operating cash flow	90700000	6100000	1386.89
free cash flow	73800000	-17600000	519.32
capital expenditure	-16900000	-23700000	28.69
depreciation and amortization	-17600000	-16500000	-6.67
deferred income tax	-22300000	8800000	-353.41
stock based compensation	0	0	NaN
accounts receivables	1600000	600000	166.67
accounts payables	10000000	96200000	-89.60
inventory	41100000	-105200000	139.07
acquisitions net	1400000	3100000	-54.84
investments in property plant and equipment	-16900000	-23700000	28.69
net cash used for investing activites	-14300000	-19600000	27.04
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	0	-500000	100.00
dividends paid	0	0	NaN
net cash used provided by financing activities	-12900000	-14000000	7.86
net change in cash	31750000	-27400000	215.88
cash at end of period	31750000	-13650000	332.60
cash at beginning of period	0	13750000	-100.00

Overall Score of Quarterly Cashflow Statement

0.67 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 32 million in 2023Q2 from -27 million in 2022Q4 representing a change of 215.88%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 91 million in 2023Q2 from 6 million in 2022Q4 representing a change of 1386.89%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 74 million in 2023Q2 from -18 million in 2022Q4 representing a change of 519.32%. This indicates an increase in cash generated after accounting for capital expenditures.

  Accounts Payables: The absolute value of Accounts Payables decreased to 10 million in 2023Q2 from 96 million in 2022Q4 representing a change of -89.6%. This indicates that the company has reduced its outstanding obligations to its suppliers.

• 📉 Negative Indicators

  Capital Expenditure: Capital Expenditure increased to -17 million in 2023Q2 from -24 million in 2022Q4 representing a change of 28.69%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Accounts Receivables: Accounts Receivables increased to 2 in 2023Q2 from 1 million in 2022Q4 representing a change of 166.67%. This suggests that the company is less capable of collecting payments from its customers.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2024-01-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	0.32	51.98	-99.38
net income per share	0.54	0.65	-16.80
operating cash flow per share	0.64	1.09	-41.42
free cash flow per share	0.11	0.46	-76.25
cash per share	0.68	2.47	-72.49
book value per share	5.18	4.03	28.33
tangible book value per share	4.98	1.78	179.46
shareholders equity per share	5.16	4.03	27.97
interest debt per share	1.35	6.54	-79.33
market cap	206608000	206149200	0.22
enterprise value	253408000	447349200	-43.35
pe ratio	5.45	4.53	20.20
price to sales ratio	9.14	0.06	15942.43
pocfratio	4.62	2.71	70.71
pfcf ratio	27.3	6.48	321.06
pb ratio	0.57	0.73	-21.86
ptb ratio	0.57	0.73	-21.86
ev to sales	11.21	0.12	8967.30
enterprise value over ebitda	6.75	3.37	100.39
ev to operating cash flow	5.67	5.88	-3.51
ev to free cash flow	33.48	14.07	137.98
earnings yield	0.18	0.22	-16.80
free cash flow yield	0.04	0.15	-76.25
debt to equity	0.26	1.47	-82.22
debt to assets	0.19	0.26	-23.83
net debt to ebitda	1.25	1.81	-31.36
current ratio	3.81	0.94	303.88
interest coverage	92.31	2.33	3854.71
income quality	0.59	1.67	-64.58
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0	0.05	-100.00
research and ddevelopement to revenue	0	0.0	-100.00
intangibles to total assets	0.03	0.1	-70.00
capex to operating cash flow	0.83	0.58	42.68
capex to revenue	1.64	0.01	13308.02
capex to depreciation	1.31	0.64	105.73
stock based compensation to revenue	0.24	0.0	26316.82
graham number	7.95	7.7	3.18
roic	0.02	0.06	-71.38
return on tangible assets	0.08	0.03	159.04
graham net net	3.43	-11.63	129.52
working capital	345600000	-54700000	731.81
tangible asset value	347300000	124000000	180.08
net current asset value	345200000	-418300000	182.52
invested capital	360800000	618200000	-41.64
average receivables	240900000	54250000	344.06
average payables	36150000	64100000	-43.60
average inventory	310150000	566549999.5	-45.26
days sales outstanding	6791.48	6.15	110320.69
days payables outstanding	73.23	8.11	803.17
days of inventory on hand	0	70.04	-100.00
receivables turnover	0.05	59.34	-99.91
payables turnover	4.98	45.02	-88.93
inventory turnover	0	5.21	-100.00
roe	0.11	0.16	-34.99
capex per share	0.53	0.64	-16.42

• ROE:

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 5.45 on 2024-01-31 from 4.53 on 2022-12-31, representing a change of 20.20%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.26 on 2024-01-31 from 1.47 on 2022-12-31, representing a change of -82.22%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Negative

  Current Ratio: Current Ratio increased to 3.81 on 2024-01-31 from 0.94 on 2022-12-31, representing a change of 303.88%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Quarterly Financial Ratios

	2024-07-31 Q2	2023-06-30 Q2	Q/Q change %
PDG.L
calendar year	2024	2023	NaN
revenue per share	0.18	14.53	-98.73
net income per share	0.06	0.19	-69.30
operating cash flow per share	0.11	0.63	-82.52
free cash flow per share	0.07	0.51	-87.02
cash per share	0.15	3.78	-96.05
book value per share	0.42	4.29	-90.10
tangible book value per share	0.25	2.1	-88.06
shareholders equity per share	0.42	4.29	-90.10
interest debt per share	0.01	6.52	-99.82
market cap	309640500	212898393.68	45.44
enterprise value	297540500	382198393.68	-22.15
pe ratio	15.48	3.96	291.23
price to sales ratio	19.23	0.2	9340.08
pocfratio	32.25	4.69	587.05
pfcf ratio	53.39	5.77	825.30
pb ratio	8.37	0.69	1112.66
ptb ratio	8.37	0.69	1112.66
ev to sales	18.48	0.37	4952.98
enterprise value over ebitda	29.75	3.88	666.04
ev to operating cash flow	30.99	8.43	267.76
ev to free cash flow	51.3	10.36	395.29
earnings yield	0.02	0.06	-74.44
free cash flow yield	0.02	0.17	-89.19
debt to equity	0.02	1.43	-98.30
debt to assets	0.02	0.26	-93.84
net debt to ebitda	-1.21	1.72	-170.33
current ratio	1.84	0.97	89.20
interest coverage	40	1.16	3341.13
income quality	1.92	3.37	-43.06
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0	0	NaN
intangibles to total assets	0.27	0.09	190.85
capex to operating cash flow	0.4	0.19	112.44
capex to revenue	0.24	0.01	2818.89
capex to depreciation	1.31	0.96	36.46
stock based compensation to revenue	0	0.0	-100.00
graham number	0.74	4.25	-82.56
roic	0.07	0.03	146.07
return on tangible assets	0.12	0.01	1294.01
graham net net	0.07	-10.15	100.70
working capital	13500000	-29099999	146.39
tangible asset value	21800000	150800000	-85.54
net current asset value	10300000	-389900000	102.64
invested capital	30500000	646500001	-95.28
average receivables	None	116400000	NaN
average payables	None	830100000	NaN
average inventory	None	602700000	NaN
days sales outstanding	92.8	10.02	825.65
days payables outstanding	174	81.24	114.18
days of inventory on hand	0	58.99	-100.00
receivables turnover	0.97	8.98	-89.20
payables turnover	0.52	1.11	-53.31
inventory turnover	0	1.53	-100.00
roe	0.14	0.04	209.96
capex per share	0.04	0.12	-62.86

• ROE:

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 15.48 on 2024-07-31 Q2 from 3.96 on 2023-06-30 Q2, representing a change of 291.23%. Indicating an increase in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 1.84 on 2024-07-31 Q2 from 0.97 on 2023-06-30 Q2, representing a change of 89.20%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.02 on 2024-07-31 Q2 from 1.43 on 2023-06-30 Q2, representing a change of -98.30%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

None